130 related articles for article (PubMed ID: 10225727)
1. Two patients with acute Guillain-Barré syndrome treated with different apheresis methods.
Uetakagaito M; Horikawa H; Yoshinaka H; Tagawa Y; Yuki N
Ther Apher; 1997 Nov; 1(4):340-2. PubMed ID: 10225727
[TBL] [Abstract][Full Text] [Related]
2. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Tagawa Y; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
[TBL] [Abstract][Full Text] [Related]
3. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
4. High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.
Thomma RCM; Fokke C; Walgaard C; Vermeulen-de Jongh DMC; Tio-Gillen A; van Rijs W; van Doorn PA; Huizinga R; Jacobs BC
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37059469
[TBL] [Abstract][Full Text] [Related]
5. Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody.
Kuwabara S; Asahina M; Koga M; Mori M; Yuki N; Hattori T
Neurology; 1998 Dec; 51(6):1656-60. PubMed ID: 9855518
[TBL] [Abstract][Full Text] [Related]
6. Anti-GM1, anti-central myelin proteins, and anti-cardiolipin autoantibodies during plasma-exchange in Guillain-Barré syndrome (GBS).
Matà S; Avanzi G; Lombardo R; Cepparone F; Pinto F; Lolli F
J Clin Apher; 1998; 13(4):155-62. PubMed ID: 9886794
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
Gregson NA; Rees JH; Hughes RA
J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
[TBL] [Abstract][Full Text] [Related]
10. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
11. Immunoadsorption therapy in Guillain-Barré syndrome.
Hirai K; Kihara M; Nakajima F; Miyanomae Y; Yoshioka H
Pediatr Neurol; 1998 Jul; 19(1):55-7. PubMed ID: 9682887
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
13. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
14. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
16. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
18. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
[TBL] [Abstract][Full Text] [Related]
19. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.
Koga M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):513-6. PubMed ID: 10201426
[TBL] [Abstract][Full Text] [Related]
20. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]